Artemether attenuates LPS-induced inflammatory bone loss by inhibiting osteoclastogenesis and bone resorption via suppression of MAPK signaling pathway

Matrine prevents bone loss in ovariectomized mice by inhibiting RANKL-induced osteoclastogenesis

(2017) Xiao Chen et al.   FASEB JOURNAL

Inflammation, fracture and bone repair

(2016) Florence Loi et al.   BONE

Alexidine Dihydrochloride Attenuates Osteoclast Formation and Bone Resorption and Protects Against LPS-Induced Osteolysis

(2016) Xiang Zhu et al.   JOURNAL OF BONE AND MINERAL RESEARCH

Emperor's new clothes: Is particle disease really infected particle disease?

(2016) Marcin K. Wasko et al.   JOURNAL OF ORTHOPAEDIC RESEARCH

Myricetin prevents titanium particle-induced osteolysis in vivo and inhibits RANKL-induced osteoclastogenesis in vitro

(2015) Chuanlong Wu et al.   BIOCHEMICAL PHARMACOLOGY

Leonurine hydrochloride inhibits osteoclastogenesis and prevents osteoporosis associated with estrogen deficiency by inhibiting the NF-κB and PI3K/Akt signaling pathways

(2015) Feng-Lai Yuan et al.   BONE

Decursin inhibits osteoclastogenesis by downregulating NFATc1 and blocking fusion of pre-osteoclasts

(2015) Kwang-Jin Kim et al.   BONE

Epoxyeicosanoids suppress osteoclastogenesis and prevent ovariectomy-induced bone loss

(2015) Hanfeng Guan et al.   FASEB JOURNAL

Antimalarial Drug Artemether Inhibits Neuroinflammation in BV2 Microglia Through Nrf2-Dependent Mechanisms

(2015) Uchechukwu P. Okorji et al.   MOLECULAR NEUROBIOLOGY

Andrographolide suppresses RANKL-induced osteoclastogenesisin vitroand prevents inflammatory bone lossin vivo

(2013) Z J Zhai et al.   BRITISH JOURNAL OF PHARMACOLOGY

New regulation mechanisms of osteoclast differentiation

(2012) Tomoki Nakashima et al.   Annals of the New York Academy of Sciences

Particle disease: Biologic mechanisms of periprosthetic osteolysis in total hip arthroplasty

(2012) Jiri Gallo et al.   Innate Immunity

Bone resorption in syndromes of the Ras/MAPK pathway

(2010) DA Stevenson et al.   CLINICAL GENETICS

Bone development and inflammatory disease is regulated by AP-1 (Fos/Jun)

(2009) E F Wagner   ANNALS OF THE RHEUMATIC DISEASES

Osteoclasts are important for bone angiogenesis

(2009) F. C. Cackowski et al.   BLOOD

NFATc1 Induces Osteoclast Fusion Via Up-Regulation of Atp6v0d2 and the Dendritic Cell-Specific Transmembrane Protein (DC-STAMP)

(2007) Kabsun Kim et al.   MOLECULAR ENDOCRINOLOGY